News
News
- Nabriva Therapeutics Announces $25.4 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
14:00 - GlobeNewswire - INVESTIGATION ALERT: Halper Sadeh LLP Investigates PAND, PRAH, FFG, CTB; Shareholders Are Encouraged to Contact the Firm
14:00 - GlobeNewswire - BioXcel Therapeutics Appoints June Bray to Board of Directors
13:00 - GlobeNewswire - ObsEva Provides Business Outlook for 2021
02/10/2021 / 07:00 - GlobeNewswire - Sanofi, Merck KGaA, Darmstadt, Germany, and More Than 500 Sites Join Inato in Making Clinical Research More Inclusive and Efficient
01/26/2021 / 14:00 - GlobeNewswire - GCP Announces Additional Leadership Changes
01/19/2021 / 12:15 - GlobeNewswire - Philips and Merck partner to advance personalized fertility treatment
01/14/2021 / 10:00 - GlobeNewswire - TRHC’s DoseMeRx® Partners with Physiomics to Provide Precision Dosing for Oncology Medications
12/17/2020 / 15:30 - GlobeNewswire - Immutep Operational Update
12/15/2020 / 14:00 - GlobeNewswire - reMYND commences first-in-human trial of ReS19-T Alzheimer’s program
12/03/2020 / 13:00 - GlobeNewswire
Real-time